$TNGX 4 SEC Filings

Filed On	Filing
05 Oct 2026	Form 4: Crystal Adam, President, R&D Received 27,000 shares by exercise or conversion ($140K) · Sold 27,000 shares ($661K)
24 Sep 2026	Form 4: Newcomb Jessica, Principal Accounting Officer Sold 8,200 shares ($199K)
03 Sep 2026	Form 4: Crystal Adam, President, R&D Received 27,000 shares by exercise or conversion ($140K) · Sold 27,000 shares ($604K)
05 Aug 2026	Form 4: Crystal Adam, President, R&D Received 27,000 shares by exercise or conversion ($140K) · Sold 27,000 shares ($736K)
02 Jul 2026	Form 4: Crystal Adam, President, R&D Received 27,000 shares by exercise or conversion ($140K) · Sold 27,000 shares ($799K)
23 Jun 2026	Form 4: Azelby Robert, Director Received 5,740 shares as a grant or award · Granted 35,910 Stock Option (Right to Buy)
08 Jun 2026	Form 4: Ketchum John B, Director Received 4,000 shares as a grant or award · Granted 25,000 Stock Option (Right to Buy)
08 Jun 2026	Form 4: Calhoun Lesley Ann, Director Received 4,000 shares as a grant or award · Granted 25,000 Stock Option (Right to Buy)
08 Jun 2026	Form 4: Rothenberg Mace, Director Received 4,000 shares as a grant or award · Granted 25,000 Stock Option (Right to Buy)
08 Jun 2026	Form 4: Lee Sung, Director Received 570 shares as a grant or award · Granted 3,570 Stock Option (Right to Buy)
03 Jun 2026	Form 4: Crystal Adam, President, R&D Received 27,000 shares by exercise or conversion ($140K) · Sold 27,000 shares ($618K)
05 May 2026	Form 4: Crystal Adam, President, R&D Received 27,000 shares by exercise or conversion ($140K) · Sold 27,000 shares ($573K)
05 May 2026	Form 4: Gall Matthew, Chief Financial Officer Received 40,000 shares as a grant or award · Granted 240,000 Stock Option (Right to Buy)
01 May 2026	Form 4: Lee Sung, Director Received 12,300 shares as a grant or award · Granted 5,200 Stock Option (Right to Buy)
16 Apr 2026	Form 4: Crystal Adam, President, R&D Received 38,460 shares by exercise or conversion ($200K) · Sold 38,460 shares ($962K)
02 Apr 2026	Form 4: Crystal Adam, President, R&D Received 27,000 shares by exercise or conversion ($140K) · Sold 27,000 shares ($572K)
27 Mar 2026	Form 4: Crystal Adam, President, R&D Received 12,000 shares by exercise or conversion ($62.4K) · Sold 12,000 shares ($241K)
09 Mar 2026	Form 4: Crystal Adam, President, R&D Sold 20,251 shares ($304K)
27 Feb 2026	Form 4: Crystal Adam, President, R&D Sold 54,345 shares ($694K)
04 Feb 2026	Form 4: Beckman Daniella, Chief Financial Officer Received 44,330 shares as a grant or award · Granted 265,980 Stock Option (Right to Buy) · Sold 10,317 shares ($127K)

Comments